Clinical trialObservationalCompleted
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
- Outcome
- Finished, no results posted
- Phase
- Observational
- Status
- Completed
- Study type
- Observational
- Start
- 29 October 1991
- Enrollment
- 273 participants
- Sites
- 1
- Primary outcomes
- To determine an approach to the localization and management of tumor in patients with ZES.
- Sponsor type
- NIH
- Results posted
- No
- Last update
- 5 November 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
Detailed description public domain (ClinicalTrials.gov)
This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.